Body iron stores and the risk of type 2 diabetes in middle-aged men

European Journal of Endocrinology

Volumn 169, Issue 2, 2013, Pages 247-253

  Aregbesola, Alex ^a   Voutilainen, Sari ^a   Virtanen, Jyrki K ^a   Mursu, Jaakko ^a   Tuomainen, Tomi Pekka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; GLUCOSE; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; COHORT ANALYSIS; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; IRON DEFICIENCY; IRON DEPLETION; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FERRITINS; FINLAND; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, TRANSFERRIN; RISK FACTORS;

EID: 84880933767     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0145     Document Type: Article

References (39)

1. Moczulski DK, GrzeszczakW& Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001 24 1187-1191. (doi:10.2337/diacare.24.7.1187)
2. Oberley LW. Free radicals and diabetes.Free Radical Biology&Medicine 1988 5 113-124. (doi:10.1016/0891-5849(88)90036-6)
3. Drews G, Krippeit-Drews P & Dufer M. Oxidative stress and b-cell dysfunction. Pflugers Archiv 2010 460 703-718. (doi:10.1007/ s00424-010-0862-9)
4. Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its complications. Journal of the Royal Society for the Promotion of Health 2002 122 28-34. (doi:10.1177/14664240021 2200112)
5. Sharifi F, Nasab NM & Zadeh HJ. Elevated serum ferritin concentrations in prediabetic subjects. Diabetes & Vascular Disease Research 2008 5 15-18. (doi:10.3132/dvdr.2008.003)
6. Syrovatka P, Kraml P, Potockova J, Fialova L, Vejrazka M, Crkovska J & Andel M. Relationship between increased body iron stores, oxidative stress and insulin resistance in healthy men. Annals of Nutrition and Metabolism 2009 54 268-274. (doi:10.1159/000229507)
7. Suarez-Ortegon MF, Arbelaez A, Mosquera M, Mendez F & Aguilar-de Plata C. Body iron stores as predictors of insulin resistance in apparently healthy urban Colombian men. Biological Trace Element Research 2012 145 283-285. (doi:10.1007/ s12011-011-9192-9)
8. Dongiovanni P, Fracanzani AL, Fargion S & Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. Journal of Hepatology 2011 55 920-932. (doi:10.1016/ j.jhep.2011.05.008)
9. Skikne BS, Flowers CH & Cook JD. Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 1990 75 1870-1876.
10. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT & Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: Results from the EPIC-Norfolk prospective study. Diabetologia 2007 50 949-956. (doi:10.1007/s00125-007-0604-5)
11. Skikne BS. Serum transferrin receptor. American Journal of Hematology 2008 83 872-875. (doi:10.1002/ajh.21279)
12. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM & Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: Case-control study. BMJ 1998 317 727. (doi:10.1136/bmj.317.7160.727)
13. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N & Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. Journal of the American Medical Association 2004 291 711-717. (doi:10.1001/jama.291.6.711)
14. Fumeron F, Pean F, Driss F, Balkau B, Tichet J, Marre M & Grandchamp B. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: The data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 2006 29 2090-2094. (doi:10.2337/ dc06-0093)
15. Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL & Pankow JS. A prospective study of plasma ferritin level and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology 2007 165 1047-1054. (doi:10.1093/aje/ kwk093)
16. Montonen J, Boeing H, Steffen A, Lehmann R, Fritsche A, Joost HG, Schulze MB & Pischon T. Body iron stores and risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 2012 55 2613-2621. (doi:10.1007/s00125-012-2633-y)
17. Kolberg JA, Jorgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, Rowe MW, Urdea MS, Xu XM, Hansen T et al. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009 32 1207-1212. (doi:10.2337/dc08-1935)
18. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Negassa A, Kabat GC, Rohan TE & Crandall J. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes, Obesity & Metabolism 2009 11 472-479. (doi:10.1111/j.1463-1326.2008.00985.x)
19. Bao W, Rong Y, Rong S & Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: A systematic review and meta-analysis. BMC Medicine 2012 10 119. (doi:10.1186/1741-7015-10-119)
20. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Annals of Clinical Research 1988 20 46-50.
21. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J & Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. New England Journal of Medicine 1994 330 1549-1554. (doi:10.1056/NEJM199406023302201)
22. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R & Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992 86 803-811. (doi:10.1161/01.CIR.86.3.803)
23. Tuomainen TP, Punnonen K, Nyyssonen K & Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998 97 1461-1466. (doi:10.1161/01.CIR.97.15.1461)
24. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT & Kuopio Ischemic Heart Disease Risk Factor Study. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001 103 2674-2680. (doi:10.1161/01.CIR. 103.22.2674)
25. Virtanen JK, Nurmi T, Voutilainen S, Mursu J & Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. European Journal of Nutrition 2011 50 305-312. (doi:10.1007/s00394-010-0138-3)
26. Salonen JT. Liver damage and protective effect of high density lipoprotein cholesterol. BMJ 2003 327 1082-1083. (doi:10.1136/ bmj.327.7423.1082)
27. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA & Salonen JT. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997 20 426-428. (doi:10.2337/diacare.20.3.426)
28. Halsall DJ, McFarlane I, Luan J, Cox TM & Wareham NJ. Typical type 2 diabetes mellitus and HFE gene mutations: A populationbased case-control study. Human Molecular Genetics 2003 12 1361-1365. (doi:10.1093/hmg/ddg149)
29. Fernandez-Real JM, Lopez-Bermejo A & Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clinical Chemistry 2005 51 1201-1205. (doi:10.1373/clinchem.2004. 046847)
30. Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998 21 2190. (doi:10.2337/ diacare.21.12.2190b)
31. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E & Fargion S. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: Evidence from a case-control study. American Journal of Gastroenterology 2007 102 1251-1258. (doi:10.1111/j.1572-0241.2007.01192.x)
32. Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G & Manco M. Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. Diabetes Care 2008 31 3-8. (doi:10.2337/dc07-0939)
33. Ozdemir A, Sevinc C, Selamet U, Kamaci B & Atalay S. Ageand body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women. Annals of Saudi Medicine 2007 27 356-361. (doi:10.4103/0256-4947.51476)
34. Ford ES, Cowie CC, Li C, Handelsman Y & Bloomgarden ZT. Irondeficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. Journal of Diabetes 2011 3 67-73. (doi:10.1111/ j.1753-0407.2010.00100.x)
35. Shakoury-ElizehM,ProtchenkoO,BergerA,Cox J,GableK,DunnTM, Prinz WA, Bard M & Philpott CC. Metabolic response to iron deficiency in Saccharomyces cerevisiae. Journal of Biological Chemistry 2010 285 14823-14833. (doi:10.1074/jbc.M109.091710)
36. Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. Journal of Investigative Medicine 2004 52 19-23.
37. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC et al. Adipocyte iron regulates adiponectin and insulin sensitivity. Journal of Clinical Investigation 2012 122 3529-3540. (doi:10.1172/ JCI44421)
38. Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B & Stehouwer CD. Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diabetes Care 2013 36 309-315. (doi:10.2337/dc12-0505)
39. Punnonen K, Irjala K & Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997 89 1052-1057.